JPMORGAN CHASE & CO - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 3 filers reported holding MYOVANT SCIENCES LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$1,442
-100.0%
53,492
-71.5%
0.00%
Q3 2022$3,369,000
+15.7%
187,514
-20.0%
0.00%
Q2 2022$2,913,000
+1300.5%
234,391
+1396.9%
0.00%
Q1 2022$208,000
-9.6%
15,658
+5.6%
0.00%
Q4 2021$230,000
-23.8%
14,828
+10.1%
0.00%
Q3 2021$302,000
+1.0%
13,468
+2.4%
0.00%
Q2 2021$299,000
+18.2%
13,156
+7.0%
0.00%
Q1 2021$253,000
+190.8%
12,296
+289.6%
0.00%
Q4 2020$87,000
+107.1%
3,156
+17.1%
0.00%
Q3 2020$42,000
-33.3%
2,695
-12.7%
0.00%
Q2 2020$63,000
+85.3%
3,088
-29.8%
0.00%
Q1 2020$34,000
-65.7%
4,396
-31.4%
0.00%
Q4 2019$99,000
-92.6%
6,407
-97.5%
0.00%
Q3 2019$1,329,000
+27.9%
255,577
+127.5%
0.00%
Q2 2019$1,039,000
-47.8%
112,361
+34.7%
0.00%
Q1 2019$1,991,000
-0.4%
83,420
-31.5%
0.00%
Q4 2018$2,000,000
-17.8%
121,864
+33.0%
0.00%
Q3 2018$2,432,000
-14.0%
91,595
-25.9%
0.00%
-100.0%
Q2 2018$2,828,000
+24.3%
123,663
+15.6%
0.00%
Q1 2018$2,275,000
+78.7%
106,944
+6.2%
0.00%
Q4 2017$1,273,000
-7.9%
100,681
+10.4%
0.00%
Q3 2017$1,382,000
+53.4%
91,213
+18.4%
0.00%
Q2 2017$901,000
-7.6%
77,010
-7.3%
0.00%
Q1 2017$975,000
+23.3%
83,070
+30.6%
0.00%
Q4 2016$791,00063,5960.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 1,000,000$26,960,00020.95%
Flow State Investments, L.P. 280,010$7,549,0706.58%
BARDIN HILL MANAGEMENT PARTNERS LP 870,776$23,4765.13%
Alpine Global Management, LLC 536,614$14,4674.81%
CARLSON CAPITAL L P 1,805,249$48,669,5133.71%
NEXPOINT ASSET MANAGEMENT, L.P. 1,338,030$36,073,2892.81%
Bellevue Group AG 5,910,639$159,350,8272.12%
Kellner Capital, LLC 66,600$1,7962.10%
WATER ISLAND CAPITAL LLC 877,979$23,6702.01%
ALPINE ASSOCIATES MANAGEMENT INC. 1,307,785$35,257,8841.61%
View complete list of MYOVANT SCIENCES LTD shareholders